製品番号: HY-P0267

Melanotan (MT)-II

Name: Melanotan (MT)-II
Brand: MedChemExpress
SKU: HY-P0267
Price: 40.00 USD
Availability: InStock
Rating: 5 (1 reviews)

(別名: メラノタンII)

1 Cited Publications

カスタマーレビュー

Based on 1 publication(s) in Google Scholar

Melanotan (MT)-II is a melanocortin receptor agonist. Melanotan (MT)-II activates melanocortin receptor 3 and melanocortin receptor 4, and stimulates the release of central endogenous oxytocin. Melanotan (MT)-II reverses recognition memory impairment, increased anxiety levels and reduced exploratory tendency in zebrafish exposed to short-term high-fat diet. Melanotan (MT)-II improves impaired social behavior indicators in mouse models of autism spectrum disorder. Melanotan (MT)-II induces weight loss, reduces food intake and exerts anorectic effects. Melanotan (MT)-II increases intracavernous pressure and erectile activity in brown rats. Melanotan (MT)-II can be used in studies related to memory impairment, anxiety, reduced exploratory behavior, autism spectrum disorder, obesity and erectile dysfunction.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

純度 : 99.97%
CAS 番号: 121062-08-6
分子式: C₅₀H₆₉N₁₅O₉
分子量:1024.18

保管条件:

Sealed storage, away from moisture.

Powder -80°C, 2 years , -20°C, 1 year

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Melanotan (MT)-II 構造式

CAS 番号: 121062-08-6

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

MedChemExpress（MCE）の使用を引用している文献 Melanotan (MT)-II

Cell Rep. 2024 Nov 19;43(12):114983. [Abstract]

Customer Validation & Images

In Vivo Efficacy Study

In Vivo Efficacy Study

生物活性
- 製品説明
- IC₅₀ & Target
- Cellular Effect
- 体内実験
化学情報
Publications (1)
溶剤 & 溶解度
- 体外
純度とドキュメンテーション
参考文献
Help & FAQs
関連分類
Bioz

生物活性

製品説明

IC₅₀ & Target

MC3R

MC4R

Melanocortin Receptor アイソフォーム固有の製品をすべて表示 :

Cellular Effect

Cell Line	Type	Value	Description	References
A-375	EC₅₀	110 nM Compound: MT-II	Agonist activity at human MC1 receptor expressed in A375 cells assessed as intracellular cAMP accumulation using [3H]-cAMP by luminescence counting Agonist activity at human MC1 receptor expressed in A375 cells assessed as intracellular cAMP accumulation using [3H]-cAMP by luminescence counting	[PMID: 26218460]
A-375	IC₅₀	6.7 nM Compound: MT-II	Antagonist activity at human MC1 receptor expressed in A375 cells assessed as inhibition of MT-II-induced intracellular cAMP accumulation using [3H]-cAMP by luminescence counting Antagonist activity at human MC1 receptor expressed in A375 cells assessed as inhibition of MT-II-induced intracellular cAMP accumulation using [3H]-cAMP by luminescence counting	[PMID: 26218460]
HEK293	EC₅₀	0.02 nM Compound: MTII	Activity in mouse melanocortin-1 receptor stably expressed in HEK293 cells Activity in mouse melanocortin-1 receptor stably expressed in HEK293 cells	[PMID: 12477357]
HEK293	EC₅₀	0.021 nM Compound: MTII	Agonist activity at mouse MC1R expressed in HEK293 cells by beta-galactosidase assay Agonist activity at mouse MC1R expressed in HEK293 cells by beta-galactosidase assay	[PMID: 15615519]
HEK293	EC₅₀	0.03 nM Compound: MT-II	Activity at mouse MC1R expressed in HEK293 cells assessed as cAMP accumulation by CRE/beta-galactosidase reporter gene assay Activity at mouse MC1R expressed in HEK293 cells assessed as cAMP accumulation by CRE/beta-galactosidase reporter gene assay	[PMID: 25347033]
HEK293	EC₅₀	0.04 nM Compound: MTII	Agonist activity at mouse MC4R expressed in HEK293 cells by beta-galactosidase assay Agonist activity at mouse MC4R expressed in HEK293 cells by beta-galactosidase assay	[PMID: 15615519]
HEK293	EC₅₀	0.05 nM Compound: MTII	Agonist activity at mouse melanocortin-4 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay Agonist activity at mouse melanocortin-4 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay	[PMID: 25699138]
HEK293	EC₅₀	0.06 nM Compound: MT-II	Activity at mouse MC4R expressed in HEK293 cells assessed as cAMP accumulation by CRE/beta-galactosidase reporter gene assay Activity at mouse MC4R expressed in HEK293 cells assessed as cAMP accumulation by CRE/beta-galactosidase reporter gene assay	[PMID: 25347033]
HEK293	EC₅₀	0.087 nM Compound: MTII	Activity in mouse melanocortin-4 receptor stably expressed in HEK293 cells Activity in mouse melanocortin-4 receptor stably expressed in HEK293 cells	[PMID: 12477357]
HEK293	EC₅₀	0.16 nM Compound: MTII	Activity in mouse melanocortin-3 receptor (mMC3R) stably expressed in HEK293 cells Activity in mouse melanocortin-3 receptor (mMC3R) stably expressed in HEK293 cells	[PMID: 12477357]
HEK293	EC₅₀	0.16 nM Compound: MTII	Activity in mouse melanocortin-5 receptor stably expressed in HEK293 cells Activity in mouse melanocortin-5 receptor stably expressed in HEK293 cells	[PMID: 12477357]
HEK293	EC₅₀	0.17 nM Compound: MTII	Agonist activity at mouse MC3R expressed in HEK293 cells by beta-galactosidase assay Agonist activity at mouse MC3R expressed in HEK293 cells by beta-galactosidase assay	[PMID: 15615519]
HEK293	EC₅₀	0.18 nM Compound: MTII	Agonist activity at mouse MC5R expressed in HEK293 cells by beta-galactosidase assay Agonist activity at mouse MC5R expressed in HEK293 cells by beta-galactosidase assay	[PMID: 15615519]
HEK293	EC₅₀	0.18 nM Compound: MT-II	Activity at mouse MC3R expressed in HEK293 cells assessed as cAMP accumulation by CRE/beta-galactosidase reporter gene assay Activity at mouse MC3R expressed in HEK293 cells assessed as cAMP accumulation by CRE/beta-galactosidase reporter gene assay	[PMID: 25347033]
HEK293	EC₅₀	0.19 nM Compound: MT-II	Activity at mouse MC5R expressed in HEK293 cells assessed as cAMP accumulation by CRE/beta-galactosidase reporter gene assay Activity at mouse MC5R expressed in HEK293 cells assessed as cAMP accumulation by CRE/beta-galactosidase reporter gene assay	[PMID: 25347033]
HEK293	EC₅₀	0.22 nM Compound: MTII	Agonist activity at mouse melanocortin-1 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay Agonist activity at mouse melanocortin-1 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay	[PMID: 25699138]
HEK293	EC₅₀	0.3 nM Compound: 17	Activity against hMC1R transfected in HEK293 cells by intracellular cAMP accumulation Activity against hMC1R transfected in HEK293 cells by intracellular cAMP accumulation	[PMID: 16539382]
HEK293	EC₅₀	0.3 nM Compound: MTII	Activity at hMC1R transfected in HEK293 cells assessed as intracellular cAMP accumulation Activity at hMC1R transfected in HEK293 cells assessed as intracellular cAMP accumulation	[PMID: 17154518]
HEK293	EC₅₀	0.3 nM Compound: MTII	Agonist activity at human MC1R expressed in HEK293 cells assessed as stimulation of intracellular cAMP level Agonist activity at human MC1R expressed in HEK293 cells assessed as stimulation of intracellular cAMP level	[PMID: 19473029]
HEK293	EC₅₀	0.3 nM Compound: MT-II	Agonist activity at human MC1 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation Agonist activity at human MC1 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation	[PMID: 18088090]
HEK293	EC₅₀	0.35 nM Compound: MTII	Agonist activity at mouse melanocortin-3 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay Agonist activity at mouse melanocortin-3 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay	[PMID: 25699138]
HEK293	EC₅₀	0.57 nM Compound: MTII	Agonist activity at mouse melanocortin-5 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay Agonist activity at mouse melanocortin-5 receptor transfected in HEK293 cells after 6 hrs by beta-galactosidase reporter gene assay	[PMID: 25699138]
HEK293	EC₅₀	1 nM Compound: MT-II	Activity at human MC1R expressed in HEK293 cells assessed by measuring intracellular cAMP accumulation Activity at human MC1R expressed in HEK293 cells assessed by measuring intracellular cAMP accumulation	[PMID: 16931008]
HEK293	EC₅₀	1.02 nM Compound: MT-II	Activity at human MC1 receptor expressed in HEK293 cells assessed as cAMP accumulation by luminescence counter Activity at human MC1 receptor expressed in HEK293 cells assessed as cAMP accumulation by luminescence counter	[PMID: 25699148]
HEK293	EC₅₀	1.02 nM Compound: MT-II	Agonist activity at human MC1R expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation Agonist activity at human MC1R expressed in HEK293 cells assessed as increase in intracellular cAMP accumulation	[PMID: 21486697]
HEK293	EC₅₀	1.8 nM Compound: MT-II	Agonist activity at human melanocortin 1 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation incubated for 3 mins in presence of IBMX Agonist activity at human melanocortin 1 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation incubated for 3 mins in presence of IBMX	[PMID: 26599352]
HEK293	EC₅₀	1.8 nM Compound: MT-II	Agonist activity at human melanocortin 3 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation incubated for 3 mins in presence of IBMX Agonist activity at human melanocortin 3 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation incubated for 3 mins in presence of IBMX	[PMID: 26599352]
HEK293	EC₅₀	1.85 nM Compound: MT-II	Agonist activity at human MC3 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation Agonist activity at human MC3 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation	[PMID: 18088090]
HEK293	EC₅₀	1.9 nM Compound: 17	Activity against hMC3R transfected in HEK293 cells by intracellular cAMP accumulation Activity against hMC3R transfected in HEK293 cells by intracellular cAMP accumulation	[PMID: 16539382]
HEK293	EC₅₀	1.9 nM Compound: MTII	Activity at hMC3R transfected in HEK293 cells assessed as intracellular cAMP accumulation Activity at hMC3R transfected in HEK293 cells assessed as intracellular cAMP accumulation	[PMID: 17154518]
HEK293	EC₅₀	1.9 nM Compound: MTII	Agonist activity at human MC3R expressed in HEK293 cells assessed as stimulation of intracellular cAMP level Agonist activity at human MC3R expressed in HEK293 cells assessed as stimulation of intracellular cAMP level	[PMID: 19473029]
HEK293	EC₅₀	2.1 nM Compound: MT-II	Agonist activity at human MC4 receptor expressed in HEK293 cells assessed as cAMP accumulation by luminescence counter Agonist activity at human MC4 receptor expressed in HEK293 cells assessed as cAMP accumulation by luminescence counter	[PMID: 25699148]
HEK293	EC₅₀	2.1 nM Compound: MT-II	Agonist activity at human MC4R expressed in HEK293 cells assessed as intracellular cAMP accumulation Agonist activity at human MC4R expressed in HEK293 cells assessed as intracellular cAMP accumulation	[PMID: 21486697]
HEK293	EC₅₀	2.3 nM Compound: MT-II	Activity at human MC4R expressed in HEK293 cells assessed by measuring intracellular cAMP accumulation Activity at human MC4R expressed in HEK293 cells assessed by measuring intracellular cAMP accumulation	[PMID: 16931008]
HEK293	EC₅₀	2.4 nM Compound: MT-II	Activity at human MC3R expressed in HEK293 cells assessed by measuring intracellular cAMP accumulation Activity at human MC3R expressed in HEK293 cells assessed by measuring intracellular cAMP accumulation	[PMID: 16931008]
HEK293	EC₅₀	2.87 nM Compound: MT-II	Agonist activity at human MC4 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation Agonist activity at human MC4 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation	[PMID: 18088090]
HEK293	EC₅₀	2.9 nM Compound: 17	Activity against hMC4R transfected in HEK293 cells by intracellular cAMP accumulation Activity against hMC4R transfected in HEK293 cells by intracellular cAMP accumulation	[PMID: 16539382]
HEK293	EC₅₀	2.9 nM Compound: MT-II	Agonist activity at human melanocortin 4 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation incubated for 3 mins in presence of IBMX Agonist activity at human melanocortin 4 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation incubated for 3 mins in presence of IBMX	[PMID: 26599352]
HEK293	EC₅₀	2.9 nM Compound: MTII	Activity at hMC4R transfected in HEK293 cells assessed as intracellular cAMP accumulation Activity at hMC4R transfected in HEK293 cells assessed as intracellular cAMP accumulation	[PMID: 17154518]
HEK293	EC₅₀	2.9 nM Compound: MTII	Agonist activity at human MC4R expressed in HEK293 cells assessed as stimulation of intracellular cAMP level Agonist activity at human MC4R expressed in HEK293 cells assessed as stimulation of intracellular cAMP level	[PMID: 19473029]
HEK293	EC₅₀	3.1 nM Compound: MT-II	Agonist activity at EYFP-fused human MC4R expressed in HEK293 cells assessed as increase in cAMP accumulation after 30 mins by luminescent enzymatic complementation based assay Agonist activity at EYFP-fused human MC4R expressed in HEK293 cells assessed as increase in cAMP accumulation after 30 mins by luminescent enzymatic complementation based assay	[PMID: 28972753]
HEK293	EC₅₀	3.3 nM Compound: 17	Activity against hMC5R transfected in HEK293 cells by intracellular cAMP accumulation Activity against hMC5R transfected in HEK293 cells by intracellular cAMP accumulation	[PMID: 16539382]
HEK293	EC₅₀	3.3 nM Compound: MT-II	Agonist activity at human melanocortin 5 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation incubated for 3 mins in presence of IBMX Agonist activity at human melanocortin 5 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation incubated for 3 mins in presence of IBMX	[PMID: 26599352]
HEK293	EC₅₀	3.3 nM Compound: MTII	Activity at hMC5R transfected in HEK293 cells assessed as intracellular cAMP accumulation Activity at hMC5R transfected in HEK293 cells assessed as intracellular cAMP accumulation	[PMID: 17154518]
HEK293	EC₅₀	3.3 nM Compound: MTII	Agonist activity at human MC5R expressed in HEK293 cells assessed as stimulation of intracellular cAMP level Agonist activity at human MC5R expressed in HEK293 cells assessed as stimulation of intracellular cAMP level	[PMID: 19473029]
HEK293	EC₅₀	3.3 nM Compound: MT-II	Agonist activity at human MC5 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation Agonist activity at human MC5 receptor expressed in HEK293 cells assessed as intracellular cAMP accumulation	[PMID: 18088090]
HEK293	EC₅₀	33.9 nM Compound: MT-II	Agonist activity at EYFP-fused human MC3R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay Agonist activity at EYFP-fused human MC3R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay	[PMID: 28972753]
HEK293	EC₅₀	33.9 nM Compound: MT-II	Agonist activity at EYFP-fused human MC5R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay Agonist activity at EYFP-fused human MC5R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay	[PMID: 28972753]
HEK293	EC₅₀	5.1 nM Compound: MT-II	Activity at human MC3 receptor expressed in HEK293 cells assessed as cAMP accumulation by luminescence counter Activity at human MC3 receptor expressed in HEK293 cells assessed as cAMP accumulation by luminescence counter	[PMID: 25699148]
HEK293	EC₅₀	5.1 nM Compound: MT-II	Agonist activity at human MC3R expressed in HEK293 cells assessed as intracellular cAMP accumulation Agonist activity at human MC3R expressed in HEK293 cells assessed as intracellular cAMP accumulation	[PMID: 21486697]
HEK293	EC₅₀	5.7 nM Compound: MT-II	Antagonist activity at human MC5 receptor expressed in HEK293 cells assessed as cAMP accumulation by luminescence counter Antagonist activity at human MC5 receptor expressed in HEK293 cells assessed as cAMP accumulation by luminescence counter	[PMID: 25699148]
HEK293	EC₅₀	5.7 nM Compound: MT-II	Agonist activity at human MC5R expressed in HEK293 cells assessed as intracellular cAMP accumulation Agonist activity at human MC5R expressed in HEK293 cells assessed as intracellular cAMP accumulation	[PMID: 21486697]
HEK293	EC₅₀	8 nM Compound: MT-II	Activity at human MC5R expressed in HEK293 cells assessed by measuring intracellular cAMP accumulation Activity at human MC5R expressed in HEK293 cells assessed by measuring intracellular cAMP accumulation	[PMID: 16931008]
HEK293	EC₅₀	8.6 nM Compound: MT-II	Agonist activity at EYFP-fused human MC4R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay Agonist activity at EYFP-fused human MC4R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay	[PMID: 28972753]
HEK293	IC₅₀	0.1 nM Compound: MT-II	Displacement of [125I]NDP-alpha-MSH from human MC1R expressed in HEK293 cells Displacement of [125I]NDP-alpha-MSH from human MC1R expressed in HEK293 cells	[PMID: 16931008]
HEK293	IC₅₀	0.2 nM Compound: 17	Inhibitory activity against hMC1R transfected in HEK293 cells Inhibitory activity against hMC1R transfected in HEK293 cells	[PMID: 16539382]
HEK293	IC₅₀	0.2 nM Compound: MTII	Displacement of [125I]NDP-alphaMSH from human MC1 receptor expressed in HEK293 cells Displacement of [125I]NDP-alphaMSH from human MC1 receptor expressed in HEK293 cells	[PMID: 17154518]
HEK293	IC₅₀	0.2 nM Compound: MTII	Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC1R expressed in HEK293 cells Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC1R expressed in HEK293 cells	[PMID: 19473029]
HEK293	IC₅₀	0.2 nM Compound: MT-II	Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC1 receptor expressed in HEK293 cells Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC1 receptor expressed in HEK293 cells	[PMID: 18088090]
HEK293	IC₅₀	1 nM Compound: MT-II	Displacement of [125I]-NDP-alpha-MSH from human MC1 receptor expressed in HEK293 cells by gamma counting analysis Displacement of [125I]-NDP-alpha-MSH from human MC1 receptor expressed in HEK293 cells by gamma counting analysis	[PMID: 25699148]
HEK293	IC₅₀	1.07 nM Compound: MT-II	Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC4 receptor expressed in HEK293 cells Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC4 receptor expressed in HEK293 cells	[PMID: 18088090]
HEK293	IC₅₀	1.1 nM Compound: MT-II	Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 4 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 4 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis	[PMID: 26599352]
HEK293	IC₅₀	1.1 nM Compound: 17	Inhibitory activity against hMC4R transfected in HEK293 cells Inhibitory activity against hMC4R transfected in HEK293 cells	[PMID: 16539382]
HEK293	IC₅₀	1.1 nM Compound: MTII	Displacement of [125I]NDP-alphaMSH from human MC4 receptor expressed in HEK293 cells Displacement of [125I]NDP-alphaMSH from human MC4 receptor expressed in HEK293 cells	[PMID: 17154518]
HEK293	IC₅₀	1.1 nM Compound: MTII	Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC4R expressed in HEK293 cells Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC4R expressed in HEK293 cells	[PMID: 19473029]
HEK293	IC₅₀	1.2 nM Compound: MT-II	Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 1 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 1 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis	[PMID: 26599352]
HEK293	IC₅₀	1.2 nM Compound: MT-II	Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 3 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 3 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis	[PMID: 26599352]
HEK293	IC₅₀	1.25 nM Compound: MT-II	Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC3 receptor expressed in HEK293 cells Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC3 receptor expressed in HEK293 cells	[PMID: 18088090]
HEK293	IC₅₀	1.3 nM Compound: 17	Inhibitory activity against hMC3R transfected in HEK293 cells Inhibitory activity against hMC3R transfected in HEK293 cells	[PMID: 16539382]
HEK293	IC₅₀	1.3 nM Compound: MTII	Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC3R expressed in HEK293 cells Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC3R expressed in HEK293 cells	[PMID: 19473029]
HEK293	IC₅₀	1.8 nM Compound: MT-II	Displacement of [125I]NDP-alpha-MSH from human MC4R expressed in HEK293 cells Displacement of [125I]NDP-alpha-MSH from human MC4R expressed in HEK293 cells	[PMID: 16931008]
HEK293	IC₅₀	1.9 nM Compound: MT-II	Displacement of [125I]NDP-alpha-MSH from human MC3R expressed in HEK293 cells Displacement of [125I]NDP-alpha-MSH from human MC3R expressed in HEK293 cells	[PMID: 16931008]
HEK293	IC₅₀	2 nM Compound: MT-II	Displacement of [125I]-NDP-alpha-MSH from human MC3 receptor expressed in HEK293 cells by gamma counting analysis Displacement of [125I]-NDP-alpha-MSH from human MC3 receptor expressed in HEK293 cells by gamma counting analysis	[PMID: 25699148]
HEK293	IC₅₀	2 nM Compound: MTII	Displacement of [125I]NDP-alphaMSH from human MC3 receptor expressed in HEK293 cells Displacement of [125I]NDP-alphaMSH from human MC3 receptor expressed in HEK293 cells	[PMID: 17154518]
HEK293	IC₅₀	2.3 nM Compound: MT-II	Displacement of [125I]-NDP-alpha-MSH from human MC1R expressed in HEK293 cells after 40 mins by Wallac 1470 gamma counting Displacement of [125I]-NDP-alpha-MSH from human MC1R expressed in HEK293 cells after 40 mins by Wallac 1470 gamma counting	[PMID: 21486697]
HEK293	IC₅₀	2.3 nM Compound: MT-II	Displacement of [125I]-NDP-alpha-MSH from human MC4R expressed in HEK293 cells after 40 mins by Wallac 1470 gamma counting Displacement of [125I]-NDP-alpha-MSH from human MC4R expressed in HEK293 cells after 40 mins by Wallac 1470 gamma counting	[PMID: 21486697]
HEK293	IC₅₀	2.3 nM Compound: MT-II	Displacement of [125I]-NDP-alpha-MSH from human MC4 receptor expressed in HEK293 cells by gamma counting analysis Displacement of [125I]-NDP-alpha-MSH from human MC4 receptor expressed in HEK293 cells by gamma counting analysis	[PMID: 25699148]
HEK293	IC₅₀	4.2 nM Compound: MT-II	Displacement of [125I]-NDP-alpha-MSH from human MC5R expressed in HEK293 cells after 40 mins by Wallac 1470 gamma counting Displacement of [125I]-NDP-alpha-MSH from human MC5R expressed in HEK293 cells after 40 mins by Wallac 1470 gamma counting	[PMID: 21486697]
HEK293	IC₅₀	4.2 nM Compound: MT-II	Displacement of [125I]-NDP-alpha-MSH from human MC5 receptor expressed in HEK293 cells by gamma counting analysis Displacement of [125I]-NDP-alpha-MSH from human MC5 receptor expressed in HEK293 cells by gamma counting analysis	[PMID: 25699148]
HEK293	IC₅₀	7 nM Compound: MT-II	Displacement of [125I]NDP-alpha-MSH from human MC5R expressed in HEK293 cells Displacement of [125I]NDP-alpha-MSH from human MC5R expressed in HEK293 cells	[PMID: 16931008]
HEK293	IC₅₀	7.47 nM Compound: MT-II	Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC5 receptor expressed in HEK293 cells Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC5 receptor expressed in HEK293 cells	[PMID: 18088090]
HEK293	IC₅₀	7.5 nM Compound: MT-II	Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 5 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis Displacement of 125I-labeled [Nle4,DPhe7]-alpha-MSH from human melanocortin 5 receptor expressed in HEK293 cells incubated for 40 mins by gamma counting analysis	[PMID: 26599352]
HEK293	IC₅₀	7.5 nM Compound: 17	Inhibitory activity against hMC5R transfected in HEK293 cells Inhibitory activity against hMC5R transfected in HEK293 cells	[PMID: 16539382]
HEK293	IC₅₀	7.5 nM Compound: MTII	Displacement of [125I]NDP-alphaMSH from human MC5 receptor expressed in HEK293 cells Displacement of [125I]NDP-alphaMSH from human MC5 receptor expressed in HEK293 cells	[PMID: 17154518]
HEK293	IC₅₀	7.5 nM Compound: MTII	Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC5R expressed in HEK293 cells Displacement of [125I][Nle4,Dphe7]-alpha-MSH from human MC5R expressed in HEK293 cells	[PMID: 19473029]
HEK293	IC₅₀	8 nM Compound: MT-II	Displacement of [125I]-NDP-alpha-MSH from human MC3R expressed in HEK293 cells after 40 mins by Wallac 1470 gamma counting Displacement of [125I]-NDP-alpha-MSH from human MC3R expressed in HEK293 cells after 40 mins by Wallac 1470 gamma counting	[PMID: 21486697]

体内実験

Melanotan (MT)-II (20 μM, percutaneous immersion for 2 consecutive days) reverses high-fat diet-induced impairments in recognition memory, reduced exploratory behavior, and anxiety-like symptoms in zebrafish, restoring these indicators to levels comparable to those of animals fed a normal diet^[1].
Melanotan (MT)-II (2.5 μg per day; intracerebroventricular injection; continuous infusion; 7 days) rescues social ability deficits in adult male maternal immune activation (MIA) mice, increasing the social ability index score from 3.1 to 26.3^[2].
Melanotan (MT)-II (0.1-1 nM, microinjected bilaterally into the nucleus accumbens) significantly reduces 24-hour food intake in fasted C57BL/6J mice, produces a significant anorectic effect, and decreases feeding responses in ad libitum-fed mice^[3].
Melanotan (MT)-II (0.1-1 mg/kg, intravenous injection) significantly enhances the overall erectile activity in conscious rats and shortens the latency of the first erectile event in anesthetized rats^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Danio rerio, longfin phenotype (3-5 months old, ~50:50 male to female ratio, high-fat diet-induced model)^[1]
Dosage:

20 μM
Administration:

percutaneous immersion; two days
Result:

Reversed the significant reduction in time spent in the red (reinforced) arm of the Y-maze (HF + MT-II group spent significantly more time than untreated HF group, matching control group levels).
Reversed the HF diet-induced increase in time spent in the Y-maze start arm (a marker of anxiety).
Restored total object exploration time in the one-trial memory test to control group levels.

Animal Model:

C57BL/6J (4-6 month-old male; maternal immune activation model)^[2]
Dosage:

2.5 μg/day
Administration:

i.c.v.; continuous infusion; 7 days
Result:

Increased sociability index score significantly from 3.1 to 26.3.
Did not produce a significant change in social novelty scores.

Animal Model:

C57BL/6J (male, 2-3 months old, average body weight ~22 g, food-deprived for ~16 hours to induce food-motivated state)^[3]
Dosage:

0.1, 0.3, 1 nM/side
Administration:

bilateral microinjection into nucleus accumbens; single dose
Result:

Significantly decreased food intake at 1, 2, and 4 hours post-injection compared to saline.
Significantly decreased food intake at 24 hours post-injection only at 0.3 nmol/side dose compared to saline.
Showed a significant main effect of drug, time, and drug-time interaction.

Animal Model:

Sprague-Dawley (male, 225-250 g, telemetric intracavernosal pressure monitoring model)^[4]
Dosage:

0.1 mg/kg; 0.3 mg/kg; 1 mg/kg
Administration:

i.v.
Result:

Induced at least one penile erection in 4 out of 5 rats, with a mean 1.6 erections, mean latency to first erection of 2812 s, mean ICPmax of ~360 mmHg, mean AUC of ~2100 mmHg.s, and mean SUM AUC of ~3000 mmHg.s at 0.1 mg/kg.
Induced at least one penile erection in 4 out of 6 rats, with a mean 1.8 erections, mean latency to first erection of 2616 s, mean ICPmax of 472 mmHg, mean AUC of ~2200 mmHg.s, and mean SUM AUC of ~4000 mmHg.s at 0.3 mg/kg.
Induced at least one penile erection in 6 out of 8 rats, with a mean 4.8 erections, mean latency to first erection of 1780 s, mean ICPmax of 548 mmHg, mean AUC of ~2300 mmHg.s, and mean SUM AUC of 10653 mmHg.s at 1 mg/kg.

Related Protocols :

化学情報

CAS 番号 121062-08-6
性状 Solid
分子量 1024.18
分子式 C₅₀H₆₉N₁₅O₉
Color White to off-white
別名

メラノタンII
配列

Ac-{Nle}-Asp-His-{d-Phe}-Arg-Trp-Lys-NH2, (2→7)-lactam
シーケンスの短縮

Ac-{Nle}-DH-{d-Phe}-RWK-NH2, (2→7)-lactam
輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Sealed storage, away from moisture

Powder	-80°C	2 years
	-20°C	1 year

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Publications (1)

All In Vivo Efficacy Study

Sort by:

Journal Impact Factor

Cell Rep

Tak1 licenses mitochondrial transfer from astrocytes to POMC neurons to maintain glucose and cholesterol homeostasis. [Abstract]

2024 Nov 19;43(12):114983. PMID: 39565693

Melanotan (MT)-II purchased from MedChemExpress. Usage Cited in: Cell Rep. 2024 Nov 19;43(12):114983. [Abstract]

Artificial cerebrospinal fluid (aCSF) and Melanotan (MT)-II (MTII, 1 μg (in 0.5 μL of aCSF); i.c.v.), an MC3/4R agonist, were administered into the third ventricle of male adult mice. GTT was then performed, and the AUC of the GTT was calculated. Melanotan (MT)-II (MTII, 1 μg (in 0.5 μL of aCSF); i.c.v.), an MC3/4R agonist, largely reversed the impaired glucose tolerance caused by astrocytic Tak1 ablation in GTKO mice. i.c.v., intracerebroventricularly; NS, not significant.

溶剤 & 溶解度

体外:

H₂O : ≥ 100 mg/mL (97.64 mM)

* "≥" means soluble, but saturation unknown.

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

0.9764 mL

4.8820 mL

9.7639 mL

5 mM

0.1953 mL

0.9764 mL

1.9528 mL

10 mM

0.0976 mL

0.4882 mL

0.9764 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Working solution concentration: 0.22 mg/mL

This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact

MedChemExpress (MCE) .

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (287 KB)
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Wekwejt P, et al. Melanotan-II reverses memory impairment induced by a short-term HF diet. Biomed Pharmacother. 2023;165:115129. [Content Brief]

[2]. Minakova E, et al. Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism. PLoS One. 2019;14(1):e0210389. Published 2019 Jan 10. [Content Brief]

[3]. Eliason NL, et al. Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food. Neuropeptides. 2022;96:102289. [Content Brief]

[4]. Giuliano F, et al. The use of telemetry technology to test the proerectile effect of melanotan-II (MT-II) in conscious rats. Eur Urol. 2005 Jul;48(1):145-51; discussion 151-2. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
H₂O	1 mM	0.9764 mL	4.8820 mL	9.7639 mL	24.4098 mL
	5 mM	0.1953 mL	0.9764 mL	1.9528 mL	4.8820 mL
	10 mM	0.0976 mL	0.4882 mL	0.9764 mL	2.4410 mL
	15 mM	0.0651 mL	0.3255 mL	0.6509 mL	1.6273 mL
	20 mM	0.0488 mL	0.2441 mL	0.4882 mL	1.2205 mL
	25 mM	0.0391 mL	0.1953 mL	0.3906 mL	0.9764 mL
	30 mM	0.0325 mL	0.1627 mL	0.3255 mL	0.8137 mL
	40 mM	0.0244 mL	0.1220 mL	0.2441 mL	0.6102 mL
	50 mM	0.0195 mL	0.0976 mL	0.1953 mL	0.4882 mL
	60 mM	0.0163 mL	0.0814 mL	0.1627 mL	0.4068 mL
	80 mM	0.0122 mL	0.0610 mL	0.1220 mL	0.3051 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

Bioz

Keywords

Melanotan (MT)-II

1 Cited Publications

100 mg お問い合わせ

Subscribe to the

MedChemExpress

Newsletter

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

Melanotan (MT)-II

MedChemExpress（MCE）の使用を引用している文献 Melanotan (MT)-II

Melanocortin Receptor アイソフォーム固有の製品をすべて表示

生物活性

製品説明

IC50 & Target

Cellular Effect

体内実験

化学情報

Publications (1)

溶剤 & 溶解度

体外:

In Vivo Dissolution Calculator

純度とドキュメンテーション

参考文献

Help & FAQs

Complete Stock Solution Preparation Table

Melanotan (MT)-II 関連分類

HY-P0267 関連分類

Bioz

Keywords

最近チェックした製品

IC₅₀ & Target